Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine maintenance in advanced urothelial cancer
NCT01529411Phase 2Completed
- Sponsor
- SOGUG
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinflunine in urothelial carcinoma (UC), sponsored by SOGUG. Started Feb 2012; status: completed.
02
Drugs
vinflunine
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01529411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529411.